{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:03:13Z","timestamp":1792184593637,"version":"4.4.0"},"reference-count":131,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.bbapap.2020.140510","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T12:13:44Z","timestamp":1595506424000},"page":"140510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Proteomics in thyroid cancer and other thyroid-related diseases: A review of the literature"],"prefix":"10.1016","volume":"1868","author":[{"given":"Yasemin","family":"Ucal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysel","family":"Ozpinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbapap.2020.140510_bb0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.5694\/mja16.00545","article-title":"Managing thyroid disease in general practice","volume":"205","author":"Walsh","year":"2016","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.bbapap.2020.140510_bb0010","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1530\/eje.0.1430639","article-title":"Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The health study of Nord-Trondelag (HUNT)","volume":"143","author":"Bjoro","year":"2000","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0015","doi-asserted-by":"crossref","first-page":"e504","DOI":"10.14694\/EdBook_AM.2014.34.e504","article-title":"Mass spectrometry-based proteomics: from cancer biology to protein biomarkers, drug targets, and clinical applications","author":"Jimenez","year":"2014","journal-title":"Am. Soc. Clin. Oncol. Educ. Book. Am. Soc. Clin. Oncol. Annu. Meet."},{"key":"10.1016\/j.bbapap.2020.140510_bb0020","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.bbapap.2017.01.005","article-title":"Clinical applications of MALDI imaging technologies in cancer and neurodegenerative diseases","volume":"1865","author":"Ucal","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbapap.2020.140510_bb0025","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/1615-9861(200206)2:6<706::AID-PROT706>3.0.CO;2-E","article-title":"Detection of cathepsin B up-regulation in neoplastic thyroid tissues by proteomic analysis","volume":"2","author":"Srisomsap","year":"2002","journal-title":"Proteomics."},{"key":"10.1016\/j.bbapap.2020.140510_bb0030","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1530\/EJE-11-0856","article-title":"Proteomic profiling of follicular and papillary thyroid tumors","volume":"166","author":"Sofiadis","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0035","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/mc.20193","article-title":"Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue","volume":"45","author":"Brown","year":"2006","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bbapap.2020.140510_bb0040","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1210\/jc.2009-0308","article-title":"Proteomics in thyroid tumor research","volume":"94","author":"Krause","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbapap.2020.140510_bb0045","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1158\/0008-5472.CAN-07-5020","article-title":"Discovery and validation of protein abundance differences between follicular thyroid neoplasms","volume":"68","author":"Netea-Maier","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbapap.2020.140510_bb0050","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jprot.2018.03.021","article-title":"Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption\/ionisation mass spectrometry imaging","volume":"191","author":"Smith","year":"2019","journal-title":"J. Proteome"},{"key":"10.1016\/j.bbapap.2020.140510_bb0055","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.bbapap.2016.10.006","article-title":"Molecular profiles of thyroid cancer subtypes: classification based on features of tissue revealed by mass spectrometry imaging","volume":"1865","author":"Pietrowska","year":"2017","journal-title":"Biochim. Biophys. Acta - Proteins Proteomics."},{"key":"10.1016\/j.bbapap.2020.140510_bb0060","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1089\/thy.2018.0392","article-title":"Peptide profile differences of noninvasive follicular thyroid neoplasm with papillary-like nuclear features, encapsulated follicular variant, and classical papillary thyroid carcinoma: an application of matrix-assisted laser desorption\/ionization mass Spe","volume":"29","author":"Ucal","year":"2019","journal-title":"Thyroid."},{"key":"10.1016\/j.bbapap.2020.140510_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/srep23660","article-title":"Proteomics of thyroid tumours provides new insights into their molecular composition and changes associated with malignancy","volume":"6","author":"Mart\u00ednez-Aguilar","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbapap.2020.140510_bb0070","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jprot.2017.09.001","article-title":"Thyroid-associated orbitopathy and tears: a proteomics study","volume":"170","author":"Kishazi","year":"2018","journal-title":"J. Proteome"},{"key":"10.1016\/j.bbapap.2020.140510_bb0075","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/cen.13122","article-title":"Comparative proteomic analysis of tear fluid in Graves\u2019 disease with and without orbitopathy","volume":"85","author":"Aass","year":"2016","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0080","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1167\/iovs.15-16699","article-title":"Proteomics differentiate between thyroid-associated Orbitopathy and dry eye syndrome","volume":"56","author":"Matheis","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbapap.2020.140510_bb0085","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1007\/s00417-013-2446-9","article-title":"Proteomic analysis of the differences in orbital protein expression in thyroid orbitopathy","volume":"251","author":"Cheng","year":"2013","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0090","doi-asserted-by":"crossref","first-page":"E1523","DOI":"10.1210\/jc.2015-2976","article-title":"Proteomics of orbital tissue in thyroid-associated Orbitopathy","volume":"100","author":"Matheis","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbapap.2020.140510_bb0095","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJMra1501993","article-title":"Biologic and clinical perspectives on thyroid Cancer","volume":"375","author":"Fagin","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbapap.2020.140510_bb0100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mce.2015.01.021","article-title":"The proteomic 2D-DIGE approach reveals the protein voltage-dependent anion channel 2 as a potential therapeutic target in epithelial thyroid tumours","volume":"404","author":"Mato","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0105","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.4161\/cc.4.11.2142","article-title":"Ras-Raf signaling needs prohibitin","volume":"4","author":"Rajalingam","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbapap.2020.140510_bb0110","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1089\/thy.2008.0235","article-title":"Prohibitin is overexpressed in papillary thyroid carcinomas bearing the BRAF(V600E) mutation","volume":"19","author":"Franzoni","year":"2009","journal-title":"Thyroid."},{"key":"10.1016\/j.bbapap.2020.140510_bb0115","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1021\/pr050349r","article-title":"Pilot study using SELDI-TOF-MS based proteomic profile for the identification of diagnostic biomarkers of thyroid proliferative diseases","volume":"5","author":"Suriano","year":"2006","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbapap.2020.140510_bb0120","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1089\/thy.2009.0400","article-title":"Proteomic study of thyroid tumors reveals frequent up-regulation of the Ca2+ \u2212binding protein S100A6 in papillary thyroid carcinoma","volume":"20","author":"Sofiadis","year":"2010","journal-title":"Thyroid."},{"key":"10.1016\/j.bbapap.2020.140510_bb0125","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000082924","article-title":"S100A4 expression is an early event of papillary carcinoma of the thyroid","volume":"67","author":"Ito","year":"2004","journal-title":"Oncology."},{"key":"10.1016\/j.bbapap.2020.140510_bb0130","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1210\/jc.2006-0155","article-title":"Ribonucleic acid interference targeting S100A4 (Mts1) suppresses tumor growth and metastasis of anaplastic thyroid carcinoma in a mouse model","volume":"91","author":"Shi","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbapap.2020.140510_bb0135","first-page":"4157","article-title":"S100A8 and S100A9 expression is a crucial factor for dedifferentiation in thyroid carcinoma","volume":"29","author":"Ito","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbapap.2020.140510_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.euprot.2017.09.001","article-title":"Proteomic analysis reveals differential protein expression in variants of papillary thyroid carcinoma","author":"Ucal","year":"2017","journal-title":"EuPA Open Proteomics."},{"key":"10.1016\/j.bbapap.2020.140510_bb0145","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00109-011-0815-6","article-title":"S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI imaging","volume":"90","author":"Nipp","year":"2012","journal-title":"J. Mol. Med. (Berl)."},{"key":"10.1016\/j.bbapap.2020.140510_bb0150","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-015-1217-x","article-title":"A multiplexed, targeted mass spectrometry assay of the S100 protein family uncovers the isoform-specific expression in thyroid tumours","volume":"15","author":"Mart\u00ednez-Aguilar","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbapap.2020.140510_bb0155","first-page":"177","article-title":"Annexins: from structure to function","volume":"378","author":"Benz","year":"1997","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbapap.2020.140510_bb0160","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/prca.200900063","article-title":"Decreased annexin A3 expression correlates with tumor progression in papillary thyroid cancer","volume":"4","author":"Jung","year":"2010","journal-title":"Proteomics. Clin. Appl."},{"key":"10.1016\/j.bbapap.2020.140510_bb0165","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.3892\/or.2016.4567","article-title":"Unveiling a novel biomarker panel for diagnosis and classification of well-differentiated thyroid carcinomas","volume":"35","author":"Paricharttanakul","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbapap.2020.140510_bb0170","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s12094-012-0928-6","article-title":"The role of annexin A3 playing in cancers","volume":"15","author":"Wu","year":"2013","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0175","first-page":"5","article-title":"Annexin A2 and cancer: a systematic review","volume":"52","author":"Christensen","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0180","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1002\/pmic.200500833","article-title":"Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma","volume":"6","author":"Wang","year":"2006","journal-title":"Proteomics."},{"key":"10.1016\/j.bbapap.2020.140510_bb0185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1476-4598-8-79","article-title":"Discovery and identification of potential biomarkers of papillary thyroid carcinoma","volume":"8","author":"Fan","year":"2009","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbapap.2020.140510_bb0190","first-page":"547","article-title":"Haptoglobin: function and polymorphism","volume":"46","author":"Wassell","year":"2000","journal-title":"Clin. Lab."},{"key":"10.1016\/j.bbapap.2020.140510_bb0195","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1002\/cam4.2587","article-title":"Apolipoproteins and cancer","volume":"8","author":"Ren","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbapap.2020.140510_bb0200","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1672-0229(07)60018-7","article-title":"Proteomics technologies and challenges","volume":"5","author":"Cho","year":"2007","journal-title":"Genomics. Proteomics Bioinformatics."},{"key":"10.1016\/j.bbapap.2020.140510_bb0205","first-page":"139","article-title":"Preoperatively undiagnosed papillary thyroid carcinoma in patients thyroidectomized for benign multinodular goiter","volume":"62","author":"Fama","year":"2018","journal-title":"Arch. Endocrinol. Metab."},{"key":"10.1016\/j.bbapap.2020.140510_bb0210","doi-asserted-by":"crossref","first-page":"e2450","DOI":"10.7717\/peerj.2450","article-title":"Tissue and serum samples of patients with papillary thyroid cancer with and without benign background demonstrate different altered expression of proteins","volume":"4","author":"Abdullah","year":"2016","journal-title":"PeerJ."},{"issue":"6","key":"10.1016\/j.bbapap.2020.140510_bb0215","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1631\/jzus.2005.B1045","article-title":"Acute phase reaction and acute phase proteins","volume":"B","author":"Gruys","year":"2005","journal-title":"J. Zhejiang Univ. Sci."},{"key":"10.1016\/j.bbapap.2020.140510_bb0220","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-019-0282-2","article-title":"Exosomes: biogenesis, biologic function and clinical potential","volume":"9","author":"Zhang","year":"2019","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bbapap.2020.140510_bb0225","doi-asserted-by":"crossref","first-page":"e1027472","DOI":"10.1080\/2162402X.2015.1027472","article-title":"The exosomes in tumor immunity","volume":"4","author":"Liu","year":"2015","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.bbapap.2020.140510_bb0230","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1530\/ERC-17-0547","article-title":"Proteomics study of serum exosomes from papillary thyroid cancer patients","volume":"25","author":"Luo","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbapap.2020.140510_bb0235","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-017-3823-2","article-title":"Decreased expression of the \u03b2(2) integrin on tumor cells is associated with a reduction in liver metastasis of colorectal cancer in mice","volume":"17","author":"Benedicto","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbapap.2020.140510_bb0240","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1038\/sj.onc.1205298","article-title":"Src kinase contributes to the metastatic spread of carcinoma cells","volume":"21","author":"Boyer","year":"2002","journal-title":"Oncogene."},{"key":"10.1016\/j.bbapap.2020.140510_bb0245","first-page":"5408","article-title":"Talin1 knockdown prohibits the proliferation and migration of colorectal cancer cells via the EMT signaling pathway","volume":"18","author":"Ji","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbapap.2020.140510_bb0250","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nrc3050","article-title":"The calpain system and cancer","volume":"11","author":"Storr","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbapap.2020.140510_bb0255","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.phrs.2015.01.003","article-title":"Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors","volume":"94","author":"Roskoski","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbapap.2020.140510_bb0260","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.5213\/inj.1612720.360","article-title":"Urine proteomics in the era of mass spectrometry","volume":"20","author":"Beasley-Green","year":"2016","journal-title":"Int. Neurourol. J."},{"key":"10.1016\/j.bbapap.2020.140510_bb0265","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.clinbiochem.2018.01.008","article-title":"iTRAQ analysis of urinary proteins: potential use of gelsolin and osteopontin to distinguish benign thyroid goiter from papillary thyroid carcinoma","volume":"53","author":"Jayapalan","year":"2018","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bbapap.2020.140510_bb0270","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0955-0674(99)80012-X","article-title":"Functions of gelsolin: motility, signaling, apoptosis, cancer","volume":"11","author":"Kwiatkowski","year":"1999","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0275","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1006446108411","article-title":"Downregulation of gelsolin correlates with the progression to breast carcinoma","volume":"65","author":"Winston","year":"2001","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbapap.2020.140510_bb0280","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.3892\/mmr.2016.5652","article-title":"Overexpression of gelsolin reduces the proliferation and invasion of colon carcinoma cells","volume":"14","author":"Li","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbapap.2020.140510_bb0285","first-page":"3228 LP","article-title":"Gelsolin: a candidate for suppressor of human bladder Cancer","volume":"55","author":"Tanaka","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbapap.2020.140510_bb0290","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ygyno.2010.10.005","article-title":"Overexpression of gelsolin in human cervical carcinoma and its clinicopathological significance","volume":"120","author":"Liao","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0295","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.3892\/ol.2015.3002","article-title":"Gelsolin regulates proliferation, apoptosis, migration and invasion in human oral carcinoma cells","volume":"9","author":"Deng","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbapap.2020.140510_bb0300","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1210\/en.2006-0923","article-title":"Gelsolin: a novel thyroid hormone receptor-beta interacting protein that modulates tumor progression in a mouse model of follicular thyroid cancer","volume":"148","author":"Kim","year":"2007","journal-title":"Endocrinology."},{"key":"10.1016\/j.bbapap.2020.140510_bb0305","doi-asserted-by":"crossref","first-page":"10343","DOI":"10.18632\/oncotarget.23130","article-title":"Thyroid follicular adenomas and carcinomas: molecular profiling provides evidence for a continuous evolution","volume":"9","author":"Dom","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.bbapap.2020.140510_bb0310","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1586\/14737159.8.1.83","article-title":"Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis","volume":"8","author":"Nikiforova","year":"2008","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"10.1016\/j.bbapap.2020.140510_bb0315","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jprot.2017.07.003","article-title":"Identification of novel biomarker and therapeutic target candidates for diagnosis and treatment of follicular carcinoma","volume":"166","author":"Lai","year":"2017","journal-title":"J. Proteome"},{"key":"10.1016\/j.bbapap.2020.140510_bb0320","first-page":"271","article-title":"Identification of novel biomarker and therapeutic target candidates for diagnosis and treatment of follicular adenoma","volume":"12","author":"Lai","year":"2015","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.bbapap.2020.140510_bb0325","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1634\/theoncologist.2017-0399","article-title":"Quantitative proteomics analysis of sporadic medullary thyroid Cancer reveals FN1 as a potential novel candidate prognostic biomarker","volume":"23","author":"Zhan","year":"2018","journal-title":"Oncologist."},{"key":"10.1016\/j.bbapap.2020.140510_bb0330","doi-asserted-by":"crossref","first-page":"W867","DOI":"10.2214\/AJR.12.10370","article-title":"Current update on medullary thyroid carcinoma","volume":"201","author":"Ganeshan","year":"2013","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0335","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/mc.20474","article-title":"Proteomics study of medullary thyroid carcinomas expressing RET germ-line mutations: identification of new signaling elements","volume":"48","author":"Gorla","year":"2009","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bbapap.2020.140510_bb0340","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1158\/0008-5472.CAN-08-0413","article-title":"RET\/PTC-induced cell growth is mediated in part by epidermal growth factor receptor (EGFR) activation: evidence for molecular and functional interactions between RET and EGFR","volume":"68","author":"Croyle","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbapap.2020.140510_bb0345","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12022-015-9390-7","article-title":"Analysis of amyloid in medullary thyroid carcinoma by mass spectrometry-based proteomic analysis","volume":"26","author":"Erickson","year":"2015","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0350","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1750-3639.2012.00644.x","article-title":"Secretory sorting receptors carboxypeptidase E and secretogranin III in amyloid \u03b2-associated neural degeneration in Alzheimer\u2019s disease","volume":"23","author":"Pl\u00e1","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0355","first-page":"647","article-title":"Immunoreactive calcitonin in amyloid fibrils of medullary carcinoma of the thyroid gland. An immunogold staining technique","volume":"110","author":"Butler","year":"1986","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.bbapap.2020.140510_bb0360","doi-asserted-by":"crossref","first-page":"35475","DOI":"10.1074\/jbc.M206039200","article-title":"Amyloid fibril formation by pentapeptide and tetrapeptide fragments of human calcitonin","volume":"277","author":"Reches","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2020.140510_bb0365","doi-asserted-by":"crossref","first-page":"21332","DOI":"10.18632\/oncotarget.7237","article-title":"Genetic and epigenetic background and protein expression profiles in relation to telomerase activation in medullary thyroid carcinoma","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.bbapap.2020.140510_bb0370","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1002\/cam4.2467","article-title":"Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer","volume":"8","author":"Panebianco","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbapap.2020.140510_bb0375","doi-asserted-by":"crossref","first-page":"e11548","DOI":"10.1097\/MD.0000000000011548","article-title":"The role of TERT promoter mutations in postoperative and preoperative diagnosis and prognosis in thyroid cancer","volume":"97","author":"Jin","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bbapap.2020.140510_bb0380","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1530\/ERC-13-0210","article-title":"Highly prevalent TERT promoter mutations in aggressive thyroid cancers","volume":"20","author":"Liu","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbapap.2020.140510_bb0385","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/cyt.12346","article-title":"Thyroid cytology: a review of current international reporting systems and emerging developments","volume":"27","author":"Wise","year":"2016","journal-title":"Cytopathology."},{"key":"10.1016\/j.bbapap.2020.140510_bb0390","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/BF03349229","article-title":"Proteomic analysis of human thyroid fine needle aspiration fluid","volume":"30","author":"Giusti","year":"2007","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.bbapap.2020.140510_bb0395","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1159\/000326006","article-title":"Proteomic identification of new biomarkers and application in thyroid cytology","volume":"50","author":"Torres-Cabala","year":"2006","journal-title":"Acta Cytol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0400","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.trsl.2016.04.004","article-title":"Proteomic analysis of fine-needle aspiration in differential diagnosis of thyroid nodules","volume":"176","author":"Ciregia","year":"2016","journal-title":"Transl. Res."},{"key":"10.1016\/j.bbapap.2020.140510_bb0405","doi-asserted-by":"crossref","DOI":"10.1186\/s13000-019-0924-z","article-title":"Causes of misdiagnoses by thyroid fine-needle aspiration cytology (FNAC): our experience and a systematic review","volume":"15","author":"Zhu","year":"2020","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0410","doi-asserted-by":"crossref","first-page":"e0126472","DOI":"10.1371\/journal.pone.0126472","article-title":"Differential protein expression profiles of cyst fluid from papillary thyroid carcinoma and benign thyroid lesions","volume":"10","author":"Dinets","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbapap.2020.140510_bb0415","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1089\/thy.2011.0014","article-title":"Immunocytochemistry with cytokeratin 19 and anti-human mesothelial cell antibody (HBME1) increases the diagnostic accuracy of thyroid fine-needle aspirations: preliminary report of 150 liquid-based fine-needle aspirations with histological control","volume":"21","author":"Cochand-Priollet","year":"2011","journal-title":"Thyroid."},{"key":"10.1016\/j.bbapap.2020.140510_bb0420","doi-asserted-by":"crossref","DOI":"10.1186\/1746-1596-7-97","article-title":"Expression of CK-19, galectin-3 and HBME-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis","volume":"7","author":"de Matos","year":"2012","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0425","doi-asserted-by":"crossref","first-page":"12079","DOI":"10.18632\/oncotarget.23951","article-title":"Integrated analysis of fine-needle-aspiration cystic fluid proteome, cancer cell secretome, and public transcriptome datasets for papillary thyroid cancer biomarker discovery","volume":"9","author":"Wu","year":"2018","journal-title":"Oncotarget."},{"key":"10.1016\/j.bbapap.2020.140510_bb0430","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/pmic.201500448","article-title":"Proteomics in thyroid cytopathology: relevance of MALDI-imaging in distinguishing malignant from benign lesions","volume":"16","author":"Pagni","year":"2016","journal-title":"Proteomics."},{"key":"10.1016\/j.bbapap.2020.140510_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2019.103414","article-title":"Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples","volume":"204","author":"Lin","year":"2019","journal-title":"J. Proteome"},{"key":"10.1016\/j.bbapap.2020.140510_bb0440","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.cytogfr.2006.10.001","article-title":"The interferon regulated ubiquitin-like protein, ISG15, in tumorigenesis: friend or foe?","volume":"17","author":"Andersen","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bbapap.2020.140510_bb0445","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.canlet.2013.02.039","article-title":"An antibody-like peptide that recognizes malignancy among thyroid nodules","volume":"335","author":"Reis","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbapap.2020.140510_bb0450","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1089\/thy.2005.15.210","article-title":"Gene expression profiles reveal that DCN, DIO1, and DIO2 are underexpressed in benign and malignant thyroid tumors","volume":"15","author":"Arnaldi","year":"2005","journal-title":"Thyroid."},{"key":"10.1016\/j.bbapap.2020.140510_bb0455","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.bbapap.2016.11.020","article-title":"Proteomic profiles of thyroid tumors by mass spectrometry-imaging on tissue microarrays","volume":"1865","author":"Galli","year":"2017","journal-title":"Biochim. Biophys. Acta. Proteins Proteomics."},{"key":"10.1016\/j.bbapap.2020.140510_bb0460","doi-asserted-by":"crossref","unstructured":"A. Pappa, P. Jackson, J. Stone, P. Munro, P. Fells, C. Pennock, S. Lightman, An ultrastructural and systemic analysis of glycosaminoglycans in thyroid-associated ophthalmopathy., Eye (Lond). 12 (Pt 2) (1998) 237\u2013244. doi:https:\/\/doi.org\/10.1038\/eye.1998.57.","DOI":"10.1038\/eye.1998.57"},{"key":"10.1016\/j.bbapap.2020.140510_bb0465","first-page":"747","article-title":"Graves\u2019 ophthalmopathy: current concepts regarding pathogenesis and management","volume":"14","author":"Burch","year":"1993","journal-title":"Endocr. Rev."},{"issue":"2017","key":"10.1016\/j.bbapap.2020.140510_bb0470","first-page":"47","article-title":"Current concepts in the pathogenesis, diagnosis, and Management of Type I Chiari Malformations","volume":"100","author":"Doberstein","year":"2013","journal-title":"R. I. Med. J."},{"key":"10.1016\/j.bbapap.2020.140510_bb0475","doi-asserted-by":"crossref","first-page":"564","DOI":"10.2174\/138920211798120844","article-title":"Graves\u2019 ophthalmopathy: a review of immunogenetics","volume":"12","author":"Khalilzadeh","year":"2011","journal-title":"Curr. Genomics."},{"key":"10.1016\/j.bbapap.2020.140510_bb0480","first-page":"998","article-title":"Thyrotropin receptor expression in Graves\u2019 orbital adipose\/connective tissues: potential autoantigen in Graves\u2019 ophthalmopathy","volume":"83","author":"Bahn","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbapap.2020.140510_bb0485","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1089\/thy.2012.0119","article-title":"Proteomics of tear fluid in thyroid-associated orbitopathy","volume":"22","author":"Matheis","year":"2012","journal-title":"Thyroid."},{"key":"10.1016\/j.bbapap.2020.140510_bb0490","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1007\/s00417-013-2446-9","article-title":"Proteomic analysis of the differences in orbital protein expression in thyroid orbitopathy","volume":"251","author":"Cheng","year":"2013","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0495","doi-asserted-by":"crossref","first-page":"473","DOI":"10.5301\/ejo.5000259","article-title":"Dry eye in graves ophthalmopathy: correlation with corneal hypoesthesia","volume":"23","author":"Achtsidis","year":"2013","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0500","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1365-2265.2004.02143.x","article-title":"Clinical results of anti-inflammatory therapy in Graves\u2019 ophthalmopathy and association with thyroidal autoantibodies","volume":"61","author":"Eckstein","year":"2004","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0505","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1357-2725(99)00143-0","article-title":"Analysis of expressed sequence tags of retinal pigment epithelium: cystatin C is an abundant transcript","volume":"32","author":"Paraoan","year":"2000","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0510","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1046\/j.1523-1755.2003.00925.x","article-title":"Impact of thyroid dysfunction on serum cystatin C","volume":"63","author":"Fricker","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbapap.2020.140510_bb0515","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0026-0495(03)00316-0","article-title":"All-trans retinoic acid- and N-(4-hydroxyphenil)-retinamide-induced growth arrest and apoptosis in orbital fibroblasts in Graves\u2019 disease","volume":"52","author":"Pasquali","year":"2003","journal-title":"Metabolism."},{"key":"10.1016\/j.bbapap.2020.140510_bb0520","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35096-x","article-title":"Tear proteins calcium binding protein A4 (S100A4) and prolactin induced protein (PIP) are potential biomarkers for thyroid eye disease","volume":"8","author":"Chng","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbapap.2020.140510_bb0525","first-page":"d1356","article-title":"S100 proteins: structure, functions and pathology","volume":"7","author":"Heizmann","year":"2002","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bbapap.2020.140510_bb0530","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-015-1217-x","article-title":"A multiplexed, targeted mass spectrometry assay of the S100 protein family uncovers the isoform-specific expression in thyroid tumours","volume":"15","author":"Mart\u00ednez-Aguilar","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbapap.2020.140510_bb0535","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/bjo.2004.049742","article-title":"Limbal epithelial crypts: a novel anatomical structure and a putative limbal stem cell niche","volume":"89","author":"Dua","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0540","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/dna.2016.3472","article-title":"Prolactin-inducible protein: from breast Cancer biomarker to immune modulator-novel insights from knockout mice","volume":"35","author":"Ihedioha","year":"2016","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0545","article-title":"Combining micro-RNA and protein sequencing to detect robust biomarkers for Graves\u2019 disease and orbitopathy","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbapap.2020.140510_bb0550","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(16)00278-6","article-title":"Hyperthyroidism","volume":"388","author":"De Leo","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.bbapap.2020.140510_bb0555","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(17)30703-1","article-title":"Hypothyroidism","volume":"390","author":"Chaker","year":"2017","journal-title":"Lancet."},{"key":"10.1016\/j.bbapap.2020.140510_bb0560","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1073\/pnas.78.7.4411","article-title":"Two-dimensional gel analysis of rat liver nuclear proteins after thyroidectomy and thyroid hormone treatment","volume":"78","author":"Nikodem","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2020.140510_bb0565","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1021\/pr0701299","article-title":"Thyroid-state influence on protein-expression profile of rat skeletal muscle","volume":"6","author":"Silvestri","year":"2007","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbapap.2020.140510_bb0570","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1021\/pr060141l","article-title":"A proteomics approach to identify protein expression changes in rat liver following administration of 3,5,3\u2032-triiodo-L-thyronine","volume":"5","author":"Silvestri","year":"2006","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbapap.2020.140510_bb0575","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1210\/mend.14.7.0470","article-title":"Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray","volume":"14","author":"Feng","year":"2000","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0580","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-016-0770-8","article-title":"Plasma proteome and metabolome characterization of an experimental human thyrotoxicosis model","volume":"15","author":"Pietzner","year":"2017","journal-title":"BMC Med."},{"key":"10.1016\/j.bbapap.2020.140510_bb0585","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/ijms19010088","article-title":"Differences in the plasma proteome of patients with hypothyroidism before and after thyroid hormone replacement: a proteomic analysis","volume":"19","author":"Alfadda","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbapap.2020.140510_bb0590","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/jth.13970","article-title":"The influence of thyroid function on the coagulation system and its clinical consequences","volume":"16","author":"Elbers","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbapap.2020.140510_bb0595","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1530\/EJE-15-1249","article-title":"The hypercoagulable state in hyperthyroidism is mediated via the thyroid hormone \u03b2 receptor pathway","volume":"174","author":"Elbers","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0600","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000381769","article-title":"Effect of experimental thyrotoxicosis onto blood coagulation: a proteomics study","volume":"4","author":"Engelmann","year":"2015","journal-title":"Eur. Thyroid J."},{"key":"10.1016\/j.bbapap.2020.140510_bb0605","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves\u2019 disease","volume":"375","author":"Smith","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbapap.2020.140510_bb0610","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.clinbiochem.2016.08.014","article-title":"Proteomic analysis reveals aberrant expression of CALR and HSPA5 in thyroid tissues of Graves\u2019 disease","volume":"50","author":"Meng","year":"2017","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bbapap.2020.140510_bb0615","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3389\/fimmu.2019.00344","article-title":"Molecular insights into the relationship between autoimmune thyroid diseases and breast Cancer: a critical perspective on autoimmunity and ER stress","volume":"10","author":"Rahman","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0620","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1176\/jnp.23.4.jnp384","article-title":"Hashimoto\u2019s encephalopathy: systematic review of the literature and an additional case","volume":"23","author":"de Holanda","year":"2011","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbapap.2020.140510_bb0625","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2165\/00023210-200721100-00002","article-title":"Hashimoto\u2019s encephalopathy\u00a0: epidemiology, pathogenesis and management","volume":"21","author":"Mocellin","year":"2007","journal-title":"CNS Drugs."},{"key":"10.1016\/j.bbapap.2020.140510_bb0630","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jneuroim.2008.02.015","article-title":"Novel autoantigens recognized by CSF IgG from Hashimoto\u2019s encephalitis revealed by a proteomic approach","volume":"196","author":"Gini","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbapap.2020.140510_bb0635","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4331\/wjbc.v8.i1.81","article-title":"Use of thyroglobulin as a tumour marker","volume":"8","author":"Indrasena","year":"2017","journal-title":"World J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2020.140510_bb0640","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1089\/thy.2006.16.1131","article-title":"Toward the application of proteomics to human thyroid tissue","volume":"16","author":"Krause","year":"2006","journal-title":"Thyroid."},{"key":"10.1016\/j.bbapap.2020.140510_bb0645","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/mas.21544","article-title":"Quality control in mass spectrometry-based proteomics","volume":"37","author":"Bittremieux","year":"2018","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.bbapap.2020.140510_bb0650","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/14789450.2019.1624165","article-title":"Quality will determine the future of mass spectrometry imaging in clinical laboratories: the need for standardization","volume":"16","author":"Ucal","year":"2019","journal-title":"Expert Rev. Proteomics."},{"key":"10.1016\/j.bbapap.2020.140510_bb0655","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/nmeth.3144","article-title":"Proteogenomics: concepts, applications and computational strategies","volume":"11","author":"Nesvizhskii","year":"2014","journal-title":"Nat. Methods"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963920301576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963920301576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:53:37Z","timestamp":1761609217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570963920301576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":131,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1570963920301576"],"URL":"https:\/\/doi.org\/10.1016\/j.bbapap.2020.140510","relation":{},"ISSN":["1570-9639"],"issn-type":[{"value":"1570-9639","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteomics in thyroid cancer and other thyroid-related diseases: A review of the literature","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbapap.2020.140510","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"140510"}}